
    
      A randomised, double-blind, placebo-controlled, parallel-group, multicenter study to
      demonstrate improvement of symptoms of RLS in subjects with moderate to severe idiopathic RLS
      with daytime symptoms who take oxycodone/naloxone prolonged release (OXN PR) compared to
      subjects taking placebo (PLA).
    
  